Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE)
 
 • Company Description   
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $267.43 Daily Weekly Monthly
20 Day Moving Average: 311 shares
Shares Outstanding: 26.76 (millions)
Market Capitalization: $7,156.96 (millions)
Beta: 0.96
52 Week High: $321.12
52 Week Low: $244.54
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.69% -15.06%
12 Week -0.54% -8.06%
Year To Date -13.93% -20.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1000 ALFRED NOBEL DR
-
HERCULES,CA -
USA		 ph: 510-724-7000
fax: 1-510-7415815		 investor_relations@bio-rad.com http://www.bio-rad.com
 
 • General Corporate Information   
Officers
Norman Schwartz - Chief Executive Officer and Chairman
Norman Schwartz - President and Director
Roop K. Lakkaraju - Chief Financial Officer and Executive Vice Preside
Christine A. Tsingos - Vice President;Chief Financial Officer
Jeffrey L. Edwards - Director

Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/30/26
Share - Related Items
Shares Outstanding: 26.76
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.96
Market Capitalization: $7,156.96 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/30/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 28.85
PEG Ratio: -
Price Ratios
Price/Book: 1.04
Price/Cash Flow: 26.68
Price / Sales: 2.76
EPS Growth
vs. Year Ago Period: -25.59%
vs. Previous Quarter: -24.70%
Sales Growth
vs. Year Ago Period: 1.14%
vs. Previous Quarter: -14.58%
ROE
03/31/26 - 3.56
12/31/25 - 3.86
09/30/25 - 4.19
ROA
03/31/26 - 2.49
12/31/25 - 2.70
09/30/25 - 2.93
Current Ratio
03/31/26 - 3.21
12/31/25 - 5.62
09/30/25 - 5.44
Quick Ratio
03/31/26 - 2.37
12/31/25 - 4.19
09/30/25 - 3.94
Operating Margin
03/31/26 - 9.67
12/31/25 - 10.47
09/30/25 - 11.10
Net Margin
03/31/26 - 6.52
12/31/25 - 29.42
09/30/25 - -26.43
Pre-Tax Margin
03/31/26 - 8.58
12/31/25 - 38.54
09/30/25 - -32.95
Book Value
03/31/26 - 256.01
12/31/25 - 276.16
09/30/25 - 249.74
Inventory Turnover
03/31/26 - 1.61
12/31/25 - 1.60
09/30/25 - 1.56
Debt-to-Equity
03/31/26 - 0.12
12/31/25 - 0.16
09/30/25 - 0.18
Debt-to-Capital
03/31/26 - 10.49
12/31/25 - 13.88
09/30/25 - 15.13
 

Powered by Zacks Investment Research ©